Sabby Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Hold |
0
| – | – | – | 166 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 186 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 185 |
|
|
2016
Q2 | – | Sell |
-70,000
| Closed | -$2.77M | – | 182 |
|
|
2016
Q1 | $2.77M | Buy |
+70,000
| New | +$2.77M | 0.14% | 30 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 187 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 224 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 185 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 160 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 133 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 137 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 132 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 122 |
|
|
2013
Q4 | – | Sell |
-218,849
| Closed | -$361K | – | 107 |
|
|
2013
Q3 | $361K | Buy |
+218,849
| New | +$361K | 0.02% | 53 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 67 |
|